Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
SpotitEarly
SpotitEarly Overview
SpotitEarly develops scent based multi-cancer early detection screening test, combining proprietary AI stack with bio-detectors, to detect cancer at its early stages and save people’s lives.
Spotitearly is currently conducting a large clinical trial for screening breast, lung, colon and prostate cancers in one test. During training phase, the test showed higher sensitivity and better specificity in detecting early stages of cancer compared to any existing test on the market today.